Jeremy Symons, Senior Adviser to EPN, was quoted in The Guardian about Zeldin’s deregulatory agenda and the measurable health and economic benefits of the rules the agency plans to rollback, saying, “If you carry around an inhaler, these rollbacks are a nightmare.”